Without a strong profit motive would companies still have much incentive to pour 100s of millions of dollars into R&D for new drugs and treatments though? How much progress in healthcare is driven by the fact there’s a lot of money to be made, and how much does the US’s high prices basically subsidize cheaper healthcare for the rest of the world?